BRIEF-M Pharmaceutical Mathew Lehman resigns as President and CEO
March 15 (Reuters) - M Pharmaceutical Inc
* Mathew Lehman has resigned from board of directors and from his position as President and CEO
* Company is undertaking a search for a new CEO
* Previously announced letter of intent to acquire reformulated Orlistat from Chelatexx, LLC allowed to lapse by parties Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.